CCND1 and hepatocellular carcinoma: Because both cyclin D1 and NF-κB are associated with cellular migration [39,40], downregulation of NF-κB and cyclin D1 by MKH-DMG treatment may contribute to the inhibition of HCC cell growth and invasion.